The Role of the Immune System in Huntington’s Disease
Open accessThe DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Abstract
Huntington’s disease (HD) is characterized by a progressive course of disease until death 15–20 years after the first symptoms occur and is caused by a mutation with expanded CAG repeats in the huntingtin (htt) protein. Mutant htt (mhtt) in the striatum is assumed to be the main reason for neurodegeneration. Knowledge about pathophysiology has rapidly improved discussing influences of excitotoxicity, mitochondrial damage, free radicals, and inflammatory mechanisms. Both innate and adaptive immune systems may play an important role in HD. Activation of microglia with expression of proinflammatory cytokines, impaired migration of macrophages, and deposition of complement factors in the striatum indicate an activation of the innate immune system. As part of the adaptive immune system, dendritic cells (DCs) prime T-cell responses secreting inflammatory mediators. In HD, DCs may contain mhtt which brings the adaptive immune system into the focus of interest. These data underline an increasing interest in the peripheral immune system for pathomechanisms of HD. It is still unclear if neuroinflammation is a reactive process or if there is an active influence on disease progression. Further understanding the influence of inflammation in HD using mouse models may open various avenues for promising therapeutic approaches aiming at slowing disease progression or forestalling onset of disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“several studies have indicated that mutated HTT has an important impact on microglia and neuroinflammation during HD pathogenesis (163).”
From Microglia Function in the Central Nervous System During Health and Neurodegeneration (2017) · cites this paper as [163]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,336
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366 · cited 1×
“Huntington’s disease (HD) is an autosomal dominantly inherited disorder with a trinucleotide CAG repeat expansion ≥36 in the exon 1 of the HD gene located on chromosome 4 [1].”
BackgroundM-1/M-2 Macrophages and the Th1/Th2 Paradigm
Mills, C. D., Kincaid, K., Alt, J. M., Heilman, M. J., & Hill, A. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6166 · Cited by 3,287 · cited 1×
“More recent findings further refined this concept and indicate that macrophages can be differentiated into M1 and M2 subtypes [53, 56].”
BackgroundMangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81369-0 · Cited by 3,073
Shah, M. A., Datson, N. A., Srinidhi, L., Stanton, V. P., MacDonald, M. E., Allard, M. W., Youngman, S., Am, F., Mott, R., Draths, K., et al. (1993) · Cell · Cited by 3,055
Development of Monocytes, Macrophages, and Dendritic Cells
Geissmann, F., Manz, M. G., Jung, S., Sieweke, M. H., Merad, M., & Ley, K. (2010) · Science · doi:10.1126/science.1178331 · Cited by 3,049
Alternative Activation of Macrophages: An Immunologic Functional Perspective
Martinez, F. O., Helming, L., & Gordon, S. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132532 · Cited by 2,745 · cited 1×
“These cytokines inhibit macrophage activation but induce antibody production resulting in resolution of inflammation through endocytic clearance and trophic factor synthesis [57].”
BackgroundMellman, I., & Steinman, R. M. (2001) · Cell · doi:10.1016/s0092-8674(01)00449-4 · Cited by 2,237
Neuroinflammation in Parkinson’s disease: A target for neuroprotection?
Hirsch, E. C., & Hunot, S. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70062-6 · Cited by 1,984
Cited by
Items 101–171 of 171
Immune-microbiome interplay and its implications in neurodegenerative disorders
Uniyal, A., Tiwari, V., Rani, M., & Tiwari, V. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00807-3 · Cited by 9
Differential Diagnosis of Chorea—HIV Infection Delays Diagnosis of Huntington’s Disease by Years
Achenbach, J., Faissner, S., & Saft, C. (2021) · Brain Sciences · doi:10.3390/brainsci11060710 · Cited by 9
Self-citationRenoir, T., Pang, T. Y., Shikano, Y., Li, S., & Hannan, A. J. (2015) · Journal of Huntington s Disease · doi:10.3233/jhd-150153 · Cited by 8
Achenbach, J., Saft, C., Faissner, S., & Ellrichmann, G. (2022) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864221109750 · Cited by 8
Self-citationChowdhury, U. N., Ahmad, S., Islam, M. B., Alyami, S. A., Quinn, J. M. W., Eapen, V., & Moni, M. A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0250660 · Cited by 8
Safety of Striatal Infusion of siRNA in a Transgenic Huntington’s Disease Mouse Model
Johnson, E., Chase, K. O., McGowan, S., Mondo, E., Pfister, E. L., Mick, E. O., Friedline, R. H., Kim, J. K., Sapp, E., DiFiglia, M., et al. (2015) · Journal of Huntington s Disease · doi:10.3233/jhd-150163 · Cited by 8
The Role of MicroRNAs in Neurodegeneration: Insights from Huntington’s Disease
Mansour, R. M., Shaker, A. A. S., Abulsoud, A. I., Mageed, S. S. A., Ashraf, A., Elsakka, E. G. E., Dahab, M. I., Sadek, M. M., Awad, F. A., Lutfy, R. H., et al. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04750-7 · Cited by 7
Ryu, J. K., & McLarnon, J. G. (2016) · Europe PMC (PubMed Central) · Cited by 7
Human neural progenitor cells in central nervous system lesions
Åkesson, E., & Sundström, E. (2015) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2015.11.020 · Cited by 7
Microbiota dysbiosis impact on the immune system dysregulation in Huntington’s disease (HD)
Acharjee, P., Prasad, S. K., Singh, V. V., Ray, M., & Acharjee, A. (2025) · International review of neurobiology · doi:10.1016/bs.irn.2025.04.002 · Cited by 6
Mazurová, Y., Anděrová, M., Němečková, I., & Bezrouk, A. (2014) · BioMed Research International · doi:10.1155/2014/291531 · Cited by 6
Dhankhar, J., Agrawal, N., & Shrivastava, A. (2021) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2021.577801 · Cited by 5
Vakilian, M. (2021) · Clinical Immunology · doi:10.1016/j.clim.2021.108896 · Cited by 5
Li, J., Lin, Y., Gao, J., Yang, F., Li, C., Chen, Y., Huang, C., Song, X., Song, Z., Wu, J., et al. (2026) · Nature Biomedical Engineering · doi:10.1038/s41551-026-01621-x · Cited by 4
The Huntington’s disease drug pipeline: a review of small molecules and their therapeutic targets
Khan, S., Bano, N., Uversky, V. N., Ahamad, S., & Bhat, S. A. (2024) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2024.08.006 · Cited by 4
Pinto, J. R. D., Neto, B. F., Munhoz, L., Kerkis, I., & Araldi, R. P. (2025) · Cells · doi:10.3390/cells14130976 · Cited by 4
Coyago, M. D. L. R., & Temiño, V. E. S. (2015) · Medwave · doi:10.5867/medwave.2015.09.6293 · Cited by 4
Porcine Model of Huntington's Disease
Rausová, P., Vochozková, P., Vidinská, D., Hrnčiarová, E., Bohuslavová, B., Mačáková, M., Valeková, I., Juhás, Š., Ardan, T., Solc, P., et al. (2017) · InTech eBooks · doi:10.5772/66353 · Cited by 4
Zhou, R., Lin, X., Lin, J., Liao, Z., Ni, H., Lin, X., He, Q., & Ning, W. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103110 · Cited by 3
Study of vesicular glycolysis in health and Huntington's Disease
Cluskey, M. M. (2021) · theses.fr (ABES) · doi:10.70675/eb022640z9c3cz4467z940dz6b27765c296b · Cited by 3
Bockholt, H. J., Clemsen, J. D., Baker, B. T., Calhoun, V. D., & Paulsen, J. S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27052384 · Cited by 3
Drug repurposing for neurodegenerative diseases
Shukla, H., John, D., Banerjee, S., & Tiwari, A. K. (2024) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2024.03.035 · Cited by 3
Tarai, S., Bit, A., Reis, H. J., Palotás, A., Rizvanov, A. A., & Bissoyi, A. (2016) · BioNanoScience · doi:10.1007/s12668-016-0240-y · Cited by 3
Anti-neuroinflammatory activity of Shenqi Fuzheng Injection and its main active constituents
Wang, W., Zhang, Z., Deng, Y., Yang, Z., Hou, J., Long, H., Lei, M., & Wu, W. (2021) · BioScience Trends · doi:10.5582/bst.2021.01140 · Cited by 3
Lin, T.-W., Chang, J., Wu, Y., Sun, T., Cheng, Y., Ren, C., Pan, M., Wu, J., Chang, K., Yang, H., et al. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03307-w · Cited by 3
Neuroinflammation in Huntington’s Disease
Lee, J. D., Lo, M. W., Fung, J. N., & Woodruff, T. M. (2021) · Neuromethods · doi:10.1007/978-1-0716-1712-0_9 · Cited by 2
Cell-based immunotherapy for neurodegenerative disease: A promising avenue
Huerta, T. J., Urbina-Muñoz, V., Urra-Alvarez, V., Villablanca, C., Gómez‐Pérez, L. S., Saavedra, B., Contreras, T., & Vidal, R. L. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00816 · Cited by 2
Microglial Biology in Neuroinflammatory Disease: Pharmaco-industrial Approach to Target Validation
Möller, T., Wes, P. D., & Doller, D. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0974-2_9 · Cited by 2
Achenbach, J., Matusch, A., Elmenhorst, D., Bauer, A., & Saft, C. (2022) · Biomedicines · doi:10.3390/biomedicines10061258 · Cited by 2
Self-citationCuturic, M. (2020) · Springer eBooks · doi:10.1007/978-3-030-38606-1_8 · Cited by 2
Ouk, K., Yalçın, M., Rigat, L., Keren‐Shaul, H., David, E., Knop, A., Böttcher, C., Kramer, A., Amit, I., Relógio, A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.16.599193 · Cited by 2
Christodoulou, C. C., Demetriou, C. A., & Zamba‐Papanicolaou, E. (2025) · Cells · doi:10.3390/cells14151195 · Cited by 2
Eltarzy, M. A., Rabie, M. A., Sayed, R. H., Ahmed, M. A. E., & Ahmedy, O. A. (2026) · Drug Development Research · doi:10.1002/ddr.70238 · Cited by 2
Torkamani, S. D., Darabi, S., Norouzian, M., Bahar, R., Beirami, A. D., Moghaddam, M. H., Fathi, M., Vakili, K. G., Tahmasebinia, F., Bahrami, M., et al. (2024) · Anatomy & Cell Biology · doi:10.5115/acb.23.284 · Cited by 2
Ganguly, P. (2018) · Digital Repository Service (Northeastern University) · doi:10.17760/d20316401 · Cited by 1
Singh, J., Dhokne, M. D., Kumar, D., Datusalia, A. K., & Jangra, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13195-0.00011-9 · Cited by 1
Li, X., Zhang, C. L., Ni, H., Sun, P., Ren, J., & Huang, S. (2026) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2026.2644164 · Cited by 1
Szukiewicz, D., Almeida‐de‐Souza, J., Gryka-Marton, M., Wątroba, M., & Grabowska, A. D. (2026) · Nutrients · doi:10.3390/nu18132106 · Cited by 1
Comparative Huntington and Parkinson Disease mRNA Analysis Reveals Common Inflammatory ProcessesPreprint
Labadorf, A. T., Choi, S. H., & Myers, R. H. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/139451 · Cited by 1
Glial Cell Metabolism and Neurodegenerative Diseases: The Current Perspective
Jaldhi, Yadav, H., & Maurya, S. K. (2024) · Springer eBooks · doi:10.1007/978-981-97-4288-2_4 · Cited by 1
Inflammation Biomarkers in Huntington’s Disease
Björkqvist, M. (2023) · Contemporary clinical neuroscience · doi:10.1007/978-3-031-32815-2_11 · Cited by 1
A Two-Pronged Approach to Preeclampsia: Understanding Gene Expression and Targeting sFlt1 using RNAi
Ashar-Patel, A. (2017) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/m2rh4n · Cited by 1
White Blood Cells in Neurodegenerative Diseases in the Context of Neuroinflammation
Wełnicka, A., & Gołąb-Janowska, M. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05476-2 · Cited by 1
Özışık, O., Kara, N. S., Abbassi‐Daloii, T., Térézol, M., Kuijper, E. C., Queralt-Rosiñach, N., Jacobsen, A., Sezerman, O. U., Roos, M., Evelo, C. T., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-85580-4 · Cited by 1
Cerebrospinal Fluid Biomarkers in Huntington’s Disease
Pio, F., & Leavitt, B. R. (2023) · Contemporary clinical neuroscience · doi:10.1007/978-3-031-32815-2_2 · Cited by 1
Mehta, R., Dabhi, R., Singh, S., Shah, A., & Vijayvargia, R. (2026) · Neurochemical Research · doi:10.1007/s11064-026-04691-0 · Cited by 1
Fernández, A., Martínez‐Ramírez, C., Gómez, A., de Diego, A. M. G., Gandía, L., Casarejos, M. J., & de Diego, A. M. G. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106046 · Cited by 1
HUEI-BIN, W. (2015) · eScholarship (California Digital Library) · Cited by 1
Neuroimmune Signalling: Novel Emerging Options to Treat Neurodegeneration
Sharma, A., Pancholi, B., Sharma, A., & Garabadu, D. (2026) · Springer eBooks · doi:10.1007/978-981-95-5088-3_9
Ferguson, M. W., Scheepers, S., Palpagama, T. H., Singh‐Bains, M. K., Laighneach, A., Morris, D. W., TURNER, C., Tippett, L. J., Waldvogel, H. J., Faull, R. L. M., et al. (2026) · Communications Medicine · doi:10.1038/s43856-026-01526-5
Eissazade, N., Mosavari, H., Hemmati, D., Khoeini, T., Salari, M., Cubo, E., & Rohani, M. (2026) · Neurodegenerative Disease Management · doi:10.1080/17582024.2026.2637425
Pathophysiology of the Blood–Brain Barrier in Neuroinflammatory Diseases
Majerová, P., & Kováč, A. (2017) · Springer eBooks · doi:10.1007/978-3-319-45514-3_4
Neuroinflammation-microglia and neurodegeneration
Fathy, A. M., Mostafa, D. M., Sedeq, H. T., Hassan, H. A., Abdullah, H. W., Fawzy, M. M., Abdelgilil, M. E., Ebrahim, Y. A., & El-Sayed, W. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15702-8.00005-1
(2021) · International Journal of Neuroscience Research · doi:10.28933/ijnr-2021-08-0805
Rouka, E. C., & Kyriakou, D. S. (2015) · Journal of Biological Research - Thessaloniki · doi:10.1186/s40709-015-0037-0
Hu, Q. (2016) · TSpace (University of Toronto)
Immunobiology and Immunotherapies in Huntington's Disease
Pal, A., Kumari, G., & Kumar, S. (2024) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815238754124010007
Cognitive Disability and Inflammation in Huntington’s Disease
Alkanlı, S. S., Alkanlı, N., & Ay, A. (2025) · Springer eBooks · doi:10.1007/978-3-031-40858-8_564-1
Finding balance in Huntington's disease: PIAS1 and huntingtin in protein homeostasis
Ochaba, J. (2016) · eScholarship (California Digital Library)
Comparative Huntington And Parkinson Disease mRNA Analysis Reveals Common Inflammatory ProcessesPreprint
Labadorf, A. T. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.6084/m9.figshare.5099752
iPSC-derived microglia as a model of immune dysfunction in neurodegenerative diseases
Bunga, A. (2018) · ORCA Online Research @Cardiff (Cardiff University)
Penas, I. M. (2021) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Understanding Immunosenescence in Aging-Related DiseasesWith Quantitative Proteomics
Cao, Z. (2014) · D-Scholarship@Pitt (University of Pittsburgh)
Saliba, S. W. (2014) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Statistical Learning for Gene Expression Biomarker Detection in Neurodegenerative Diseases
Kelly, J. (2022) · PEARL (University of Plymouth) · doi:10.24382/609
Khan, T. (2016) · BRAC University Institutional Repository (BRAC University)
Neuropsychiatric symptoms and immune system parameters in Huntington's disease
Bouwens, J. A. (2018) · Leiden Repository (Leiden University)
Thiels, C., Stahl, A., Saft, C., Juckel, G., & Lücke, T. (2020) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/a-1082-6605
Self-citationBioinformatics Analysis to Reveal Potential Targets of Huntington's Disease
Yang, S., Xu, X., Liu, W., & Zhang, S. (2026) · IET Systems Biology · doi:10.1049/syb2.70088
Metadata
- Authors
- Ellrichmann, G., Reick, C., Saft, C., & Linker, R. A.
- Affiliations
- St. Josef-Hospital (DE)
- Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, 44791 Bochum, Germany
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Corresponding author
- Ellrichmann, Gisa
- Venue
- Clinical and Developmental Immunology
- Publisher
- Wiley
- Published
- 2013
- Volume
- 2013
- Pages
- 1-11
- ISSN
- 1740-2522 (ISSN-L)
- 1740-2530
- PMC
- PMC3727178
- OpenAlex
- W2147983580
- Cited by
- 155
- References
- 106
- Citations by year
- 2026: 9 · 2025: 14 · 2024: 13 · 2023: 13 · 2022: 7 · 2021: 14 · 2020: 15 · 2019: 11 · 2018: 7 · 2017: 12 · 2016: 12 · 2015: 17 · 2014: 9 · 2013: 2
- FWCI
- 1.33
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Clinical and Developmental Immunology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Teva Pharmaceutical Industries
- Cure Huntington’s Disease Initiative
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Keywords
- Huntington's disease, neuroinflammation, innate immune system, adaptive immunity, microglial activation, macrophage migration, complement deposition, dendritic cells, T cell response, mutant huntingtin, striatum, neurodegeneration, CAG repeat expansion, peripheral immune system
- MeSH terms
- Animals, Humans, Huntington Disease, Immune System, Immunity, Innate, Adaptive Immunity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.